A Study of the Prevalence of Headache in Epileptic Patients

NCT ID: NCT00277368

Last Updated: 2010-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

719 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-07-31

Study Completion Date

2006-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the prevalence, characteristics and classification of headaches in epileptic patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Headache is often ignored as a symptom of epileptic seizures. The purpose of this survey is to investigate the prevalence, characteristics and classification of seizure-associated headaches and non-seizure-associated headaches in epileptic patients in Korea, according the criteria of the International Headache Society 2004. In this survey, 577 consecutive patients with a recent diagnosis of epilepsy are interviewed by questionnaire about headaches associated with epileptic seizures. It involves questions about headache in general, localization, severity, duration and frequency, as well as headache associated with seizures, and about patient's family history. This Observational study does not involve the administration of any drugs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

001

A structured questionnaire for seizure-related headache

Intervention Type OTHER

A structured questionnaire for seizure-related headache

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A structured questionnaire for seizure-related headache

A structured questionnaire for seizure-related headache

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a recent diagnosis epilepsy
* Able to describe their symptoms by themselves
* Have had at least 2 episodes of seizures during the previous year
* Have had at least 1 headache during the previous year

Exclusion Criteria

* Well-controlled epileptic patients taking anti-epileptic medications
Minimum Eligible Age

13 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Janssen Korea, Ltd., Korea

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Janssen Korea, Ltd., Korea

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janssen Korea, Ltd. Clinical Trial

Role: STUDY_DIRECTOR

Janssen Korea, Ltd.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR003613

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Seizures Post Intracerebral Hemorrhage
NCT01115959 COMPLETED PHASE4
The Human Epilepsy Project
NCT02126774 COMPLETED
Epilepsy Impact Scale
NCT01833234 COMPLETED